CONSOLIDATED CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Income	Class B Common Stock Common Stock
Balance a the beginning at Dec. 30, 2023	$ 29,291	$ 43,228	$ 159,132	$ (176,700)	$ 268	$ 3,363
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Repurchases of Common Stock	(32)	(156)	124
Class B converted into common stock	0	18				(18)
Restricted stock grants issued	0	832	(1,235)			403
Stock-based compensation expense	156		156
Net (loss) income	(2,494)			(2,494)
Other comprehensive (loss) income	(5)				(5)
Balance at the end at Mar. 30, 2024	$ 26,916	43,922	158,177	(179,194)	263	3,748
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Repurchases of Common Stock (in shares)	52,091
Balance a the beginning at Dec. 30, 2023	$ 29,291	43,228	159,132	(176,700)	268	3,363
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(5,802)
Other comprehensive (loss) income	(15)
Balance at the end at Sep. 28, 2024	23,271	42,038	159,734	(182,502)	253	3,748
Balance a the beginning at Mar. 30, 2024	26,916	43,922	158,177	(179,194)	263	3,748
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Restricted stock grants forfeited	0	(64)	64
Repurchases of Common Stock	(313)	(1,054)	741
Common Stock issued	0	113	(113)
Restricted stock grants issued	0	96	(96)
Stock-based compensation expense	103		103
Net (loss) income	603			603
Other comprehensive (loss) income	(5)				(5)
Balance at the end at Jun. 29, 2024	$ 27,304	43,013	158,876	(178,591)	258	3,748
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Repurchases of Common Stock (in shares)	351,183
Repurchases of Common Stock	$ (236)	(975)	739
Stock-based compensation expense	119		119
Net (loss) income	(3,911)			(3,911)
Other comprehensive (loss) income	(5)				(5)
Balance at the end at Sep. 28, 2024	$ 23,271	42,038	159,734	(182,502)	253	3,748
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Repurchases of Common Stock (in shares)	324,888
Balance a the beginning at Dec. 28, 2024	$ 16,218	41,992	159,892	(189,700)	286	3,748
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Restricted stock grants forfeited	0	(4)	4
Stock-based compensation expense	101		101
Net (loss) income	(1,697)			(1,697)
Other comprehensive (loss) income	(5)				(5)
Balance at the end at Mar. 29, 2025	14,617	41,988	159,997	(191,397)	281	3,748
Balance a the beginning at Dec. 28, 2024	16,218	41,992	159,892	(189,700)	286	3,748
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(4,614)
Other comprehensive (loss) income	(15)
Balance at the end at Sep. 27, 2025	11,757	41,806	160,273	(194,314)	271	3,721
Balance a the beginning at Mar. 29, 2025	14,617	41,988	159,997	(191,397)	281	3,748
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Repurchases of Common Stock	(26)	(181)	155
Class B converted into common stock	0	27				(27)
Restricted stock grants issued	0	96	(96)
Stock-based compensation expense	61		61
Net (loss) income	1,160			1,160
Other comprehensive (loss) income	(5)				(5)
Balance at the end at Jun. 28, 2025	$ 15,807	41,930	160,117	(190,237)	276	3,721
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Repurchases of Common Stock (in shares)	60,177
Restricted stock grants forfeited	$ 0	(120)	120
Repurchases of Common Stock	(1)	(4)	3
Stock-based compensation expense	33		33
Net (loss) income	(4,077)			(4,077)
Other comprehensive (loss) income	(5)				(5)
Balance at the end at Sep. 27, 2025	$ 11,757	$ 41,806	$ 160,273	$ (194,314)	$ 271	$ 3,721
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Repurchases of Common Stock (in shares)	1,452